Sommaire

Numéro précédent | Numéro suivant

• • ·Tapping our immune potential to realise the ultimate goal

    Page :1175

     
• • ·Is there a future for auto-allo HSCT in multiple myeloma?

    Page :1176-1177

    Angela Dispenzieri

     
• • ·Cord blood meets its match

    Page :1177-1178

    Alois Gratwohl

     
• • ·Histone deacetylase inhibitors and Hodgkin’s lymphoma

    Page :1178-1179

    Mark H Kirschbaum

     
• • ·Pitfalls in extrapolating adult data to rare paediatric diseases

    Page :1180-1181

    Heidi Traunecker

     
• • ·Nocebo side-effects in cancer treatment

    Page :1181-1182

    Amit K Garg

     
• • ·Erratum

    Page :1182

    
• • ·Erratum

    Page :1182

    
• • ·Electromotive administration of mitomycin

    Page :1183

    Christopher CK Ho

     
• • ·Pelvic inflammatory disease and ovarian cancer

    Page :1183-1184

    Kelby M Cheong

    
• • ·Pelvic inflammatory disease and ovarian cancer

    Page :1184

    R van de Laar, LF Massuger

    
• • ·Pelvic inflammatory disease and ovarian cancer – Authors’ reply

    Page :1184-1185

    Hui-Wen Lin, Shiyng Yu Lin, Wei Zer Lin, Wei Li Lin, Yuen-Liang Lai

    
• • ·Intrauterine device and cervical cancer: we need more evidence

    Page :1185-1186

    Cristina Lopez-del Burgo, Alfonso Osorio, Jokin De Irala

    
• • ·Intrauterine device and cervical cancer: we need more evidence – Authors’ reply

    Page :1186-1187

    Xavier Castellsagué, Mireia Díaz, Salvatore Vaccarella, Silvia de Sanjosé, Nubia Muñoz, Rolando Herrero, Silvia Franceschi, Chris JLM Meijer, F Xavier Bosch

    
• • ·Psychological effect of breast cancer

    Page :1187

    Cordelia Galgut

    
• • ·The great divide in cancer care continues to fail Aborigines

    Page :1188

    Georgina Kenyon

     
• • ·2011 NCRI conference

    Page :1189

    Clare Sansom

    Plan Plan  
• • ·Bitumens and bitumen emissions, and some heterocyclic polycyclic aromatic hydrocarbons

    Page :1190-1191

    Beatrice Lauby-Secretan, Robert Baan, Yann Grosse, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Laurent Galichet, Kurt Straif, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group

      
• • ·Till death do us part

    Page :1192-1193

    Paul Rousseau

    
• • ·Nine letters

    Page :1193-1194

    Nicholas Wilcken

    
• • ·Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

    Page :1195-1203

    Amrita Krishnan, Marcelo C Pasquini, Brent Logan, Edward A Stadtmauer, David H Vesole, Edwin Alyea, Joseph H Antin, Raymond Comenzo, Stacey Goodman, Parameswaran Hari, Ginna Laport, Muzaffar H Qazilbash, Scott Rowley, Firoozeh Sahebi, George Somlo, Dan T Vogl, Daniel Weisdorf, Marian Ewell, Juan Wu, Nancy L Geller, Mary M Horowitz, Sergio Giralt, David G Maloney, on behalf of the Blood Marrow Transplant Clinical Trials Network (BMT CTN)

    Résumé Résumé Plan Plan   
• • ·Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial

    Page :1204-1213

    Thomas Elter, Liana Gercheva-Kyuchukova, Halyna Pylylpenko, Tadesuz Robak, Branimir Jaksic, Grigoriy Rekhtman, Sławomira Kyrcz-Krzemień, Mykola Vatutin, Jingyang Wu, Cynthia Sirard, Michael Hallek, Andreas Engert

    Résumé Résumé Plan Plan   
• • ·Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis

    Page :1214-1221

    Mary Eapen, John P Klein, Guillermo F Sanz, Stephen Spellman, Annalisa Ruggeri, Claudio Anasetti, Maria Brown, Richard E Champlin, Joan Garcia-Lopez, Gareth Hattersely, Gesine Koegler, Mary J Laughlin, Gerard Michel, Samir K Nabhan, Franklin O Smith, Mary M Horowitz, Eliane Gluckman, Vanderson Rocha, for the Eurocord-European Group for Blood and Marrow Transplantation, Netcord, and the Center for International Blood and Marrow Transplant Research

    Résumé Résumé Plan Plan  
• • ·Mocetinostat for relapsed classical Hodgkin’s lymphoma: an open-label, single-arm, phase 2 trial

    Page :1222-1228

    Anas Younes, Yasuhiro Oki, R Gregory Bociek, John Kuruvilla, Michelle Fanale, Sattva Neelapu, Amanda Copeland, Daniela Buglio, Ahmed Galal, Jeffrey Besterman, Zuomei Li, Michel Drouin, Tracy Patterson, M Renee Ward, Jessica K Paulus, Yuan Ji, L Jeffrey Medeiros, Robert E Martell

    Résumé Résumé Plan Plan   
• • ·Meningiomas in children and adolescents: a meta-analysis of individual patient data

    Page :1229-1239

    Rishi S Kotecha, Elaine M Pascoe, Elisabeth J Rushing, Lucy B Rorke-Adams, Ted Zwerdling, Xing Gao, Xin Li, Stephanie Greene, Abbas Amirjamshidi, Seung-Ki Kim, Marco A Lima, Po-Cheng Hung, Fayçal Lakhdar, Nirav Mehta, Yuguang Liu, B Indira Devi, B Jayanand Sudhir, Morten Lund-Johansen, Flemming Gjerris, Catherine H Cole, Nicholas G Gottardo

    Résumé Résumé Plan Plan   
• • ·Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis

    Page :1240-1248

    Tim Luckett, David Goldstein, Phyllis N Butow, Val Gebski, Lynley J Aldridge, Joshua McGrane, Weng Ng, Madeleine T King

    Résumé Résumé Plan Plan  
• • ·Polypharmacy in elderly patients with cancer: clinical implications and management

    Page :1249-1257

    Judith Lees, Alexandre Chan

    Résumé Résumé Plan Plan
• • ·Prevention of CNS relapse in diffuse large B-cell lymphoma

    Page :1258-1266

    Robert Kridel, Pierre-Yves Dietrich

    Résumé Résumé Plan Plan